Core Insights - Analysts project that UiPath (PATH) will report quarterly earnings of $0.03 per share, reflecting a year-over-year decline of 66.7% [1] - Revenue is expected to reach $302.92 million, which represents a 5.4% increase from the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a reevaluation of initial estimates by analysts [1] Earnings Estimates and Projections - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock [2] - There is a strong correlation between earnings estimate revisions and short-term stock price performance [2] Key Metrics Projections - Analysts estimate 'Revenue- Licenses' at $109.52 million, indicating an 8.2% decline from the previous year [4] - 'Net New ARR' is projected to be $37.53 million, down from $59 million year-over-year [4] - The average prediction for 'ARR' stands at $1.55 billion, compared to $1.31 billion from the previous year [4] Stock Performance - Over the past month, UiPath shares have increased by 8.8%, outperforming the Zacks S&P 500 composite, which saw a 2.5% change [4] - Based on its Zacks Rank 3 (Hold), PATH is expected to perform in line with the overall market in the upcoming period [4]

Core Viewpoint - UiPath's stock has significantly declined, but there are potential recovery paths through operational efficiencies and leadership changes [1][4][5]. Company Performance - UiPath's stock is down approximately 54% from recent highs and about 82% from all-time highs, reflecting broader challenges in the tech sector [4]. - The company integrated RPA technology, saving a large financial client 10,000 man-hours annually, showcasing the productivity benefits of its solutions [2][3]. - Despite a slowdown, UiPath's annual recurring revenue (ARR) grew by 21% year-over-year last quarter, and sales increased by 16% [9]. Leadership Changes - CEO Rob Enslin's sudden resignation after four months raised concerns among investors, but the return of founder Daniel Dines may stabilize the company [7][8]. - Dines has a personal stake in the company's success and may bring renewed energy and direction [8]. Financial Health - UiPath maintains a strong balance sheet with nearly $2 billion in cash and investments, no long-term debt, and a favorable current asset to liability ratio [11]. - The company has positive cash flow with a 24% margin over the last four quarters, indicating operational efficiency [9]. Market Potential - The RPA market is projected to grow at a compound annual rate of 37% through 2032, presenting significant opportunities for UiPath [12]. - UiPath's current price-to-sales (P/S) ratio of about 5.2 is lower than its recent average and below peers like GitLab and CommVault Systems, suggesting potential undervaluation [13]. Investment Considerations - While challenges exist, the market may be pricing in all negatives without recognizing the opportunities, making UiPath a speculative buy for long-term investors [14].

These stocks are oversold and poised to deliver big gains. Artificial intelligence (AI) is expected to provide the biggest increase to worker productivity since the adoption of the PC in the 1990s, and like shareholders of the leading tech companies that emerged from that period, investors could realize tremendous returns if they own the right AI stocks. If you're looking for the "right" AI stocks, here are two to consider. Once headwinds are lifted, growth could explode for these two companies and send the ...

Core Viewpoint - UiPath's stock has decreased by 45% this year, indicating significant challenges for the company as it approaches its quarterly earnings report on September 5, 2024 [1]. Company Summary - UiPath is scheduled to report its quarterly earnings on September 5, 2024, marking a critical moment for the company [1]. - The stock prices referenced were from the trading day of August 27, 2024, highlighting the recent performance context [1].

UiPath, Inc. (PATH) shares have declined 45.9% in the past six months against the 6.9% rally of the industry it belongs to and the 12.1% rise in Zacks S&P 500 composite. Six-Months Price Performance Zacks Investment Research Image Source: Compared with other close competitors, PATH's performance falls short. Oracle Corporation (ORCL) has risen 25.1% and SAP SE (SAP) has gained 16.7% over the same period. Looking at the recent performance, PATH has gained 2.6% over the past month, suggesting that there might ...

In the latest trading session, UiPath (PATH) closed at $12.64, marking a +1.85% move from the previous day. The stock's change was more than the S&P 500's daily loss of 0.32%. Elsewhere, the Dow saw an upswing of 0.16%, while the tech-heavy Nasdaq depreciated by 0.85%. The the stock of enterprise automation software developer has risen by 0.4% in the past month, lagging the Business Services sector's gain of 0.64% and the S&P 500's gain of 1.52%. The upcoming earnings release of UiPath will be of great inte ...

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends UiPath. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

RADNOR, Pa., Aug. 16, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against UiPath, Inc. ("UiPath") (NYSE: PATH). The action charges UiPath with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of UiPat ...

PHILADELPHIA, Aug. 16, 2024 (GLOBE NEWSWIRE) -- A securities fraud lawsuit has been filed against UiPath, Inc. ("UiPath" or the "Company") (NYSE: PATH). The lawsuit is captioned Steiner v. UiPath, Inc., et al., No. 1:24-cv-04702 (S.D.N.Y.), and is filed on behalf of purchasers of UiPath securities between December 1, 2023 and May 29, 2024, inclusive (the "Class Period"). CLICK HERE TO LEARN MORE ABOUT THIS LAWSUIT. Investors who purchased or acquired UiPath securities during the Class Period may, no later t ...

SAN DIEGO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UiPath, Inc. (NYSE: PATH) securities between December 1, 2023 and the close of trading on May 29, 2024, inclusive (the "Class Period"), have until this upcoming Monday, August 19, 2024 to seek appointment as lead plaintiff of the UiPath class action lawsuit. Captioned Steiner v. UiPath, Inc., No. 24-cv-04702 (S.D.N.Y.), the UiPath class action lawsuit charges UiPath and certain of UiPath's ...